These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3180365)

  • 1. [Studies on the effective components in protective sera against Plasmodium yoelii infections in mice].
    Cheng Q; Liu EX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1988; 6(2):81-6. PubMed ID: 3180365
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of karyopherin beta as an immunogenic antigen of the malaria parasite using immune mice and human sera.
    Mohmmed A; Kishore S; Patra KP; Dasaradhi PV; Malhotra P; Chauhan VS
    Parasite Immunol; 2005 May; 27(5):197-203. PubMed ID: 15987343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.
    Hunter RL; Kidd MR; Olsen MR; Patterson PS; Lal AA
    J Immunol; 1995 Feb; 154(4):1762-9. PubMed ID: 7836760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells can initiate protective immune responses against malaria.
    Bruña-Romero O; Rodriguez A
    Infect Immun; 2001 Aug; 69(8):5173-6. PubMed ID: 11447201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
    Rotman HL; Daly TM; Clynes R; Long CA
    J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice.
    Zheng W; Liu J; Meng DY; Hu XF; Cao YM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):14-8. PubMed ID: 16866134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
    Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
    Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
    J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do apoptotic Plasmodium-infected hepatocytes initiate protective immune responses?
    Renia L; Maranon C; Hosmalin A; Gruner AC; Silvie O; Snounou G
    J Infect Dis; 2006 Jan; 193(1):163-4; author reply 164-5. PubMed ID: 16323145
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmodium yoelii: cellular immune responses in splenectomized and normal mice.
    Hauda KM; Sayles PC; Wassom DL
    Exp Parasitol; 1993 Jun; 76(4):385-93. PubMed ID: 8513876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
    Doolan DL; Hoffman SL
    J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein.
    Takita-Sonoda Y; Tsuji M; Kamboj K; Nussenzweig RS; Clavijo P; Zavala F
    Exp Parasitol; 1996 Nov; 84(2):223-30. PubMed ID: 8932772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.
    Sharma SK; Farah D; Misra-Bhattacharya S; Bajpai P; Agarwal A; Mohammad O
    Vaccine; 2006 Feb; 24(7):948-56. PubMed ID: 16168527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
    Wang L; Goschnick MW; Coppel RL
    Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium yoelii: splenectomy alters the antibody responses of infected mice.
    Sayles PC; Yanez DM; Wassom DL
    Exp Parasitol; 1993 Jun; 76(4):377-84. PubMed ID: 8513875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
    Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
    Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective polyclonal antibodies by immunization with Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
    J Immunol; 1995 Aug; 155(3):1637. PubMed ID: 7636221
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes.
    Sayles PC; Wassom DL
    J Immunol; 1988 Jul; 141(1):241-8. PubMed ID: 3379305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.